Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qkk843/active) has announced the addition of the "Active Transdermal Drug Delivery to 2018" report to their offering.
The administration of therapeutic drugs via the advantages of transdermal drug delivery for improving patient compliance, particularly for the treatment of chronic conditions, are well known. But growth of transdermal delivery has been restricted by the need to limit candidate drugs to molecules small enough to effectively pass through the stratum corneum, a limitation that excludes passive transdermal patches as a viable option for the growing number of protein and peptide therapeutic compounds that will represent an increasing share of future NCEs.
New technologies that employ energy or mechanical designs to affect drug transport through the skin are expanding the type and number of drug candidates that are viable for transdermal delivery. Evolving active transdermal systems will be well-positioned to address a significant segment of the large -molecule biological drugs expected to emerge from the convergence of automated discovery and genome mapping. As designs shrink in size and become more patient-friendly, opportunities for active transdermal delivery will increase.
Key Topics Covered:
Active Transdermal Drug Delivery Market Dynamics
Active Transdermal Technology Overview
Market Drivers for Transdermal Delivery
Excipients and Penetration Enhancers
Factors Limiting Growth
Active Transdermal Technologies
Active Transdermal Design Factors
Drug Formulation Factors
Proprietary Delivery vs. 3rd Party Patches
Dosing and Rate Factors
Commercial Active Transdermal Platforms - Assessment & Prospects
Active Transdermal Delivery - Market Analysis & Forecasts
Nonviral Gene Delivery
Clinical Trial Process
Shifting Patient Demographics
Market Participant Profiles
For more information visit http://www.researchandmarkets.com/research/qkk843/active
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.